Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rakovina Therapeutics Inc. has increased its private placement offering to $2.5 million in response to high investor demand. The funds will support the advancement of novel cancer treatments using AI platforms and the development of its kt-3000 series. The offering consists of units priced at $0.06, each including a share and a warrant.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
